Regulatory and Compliance Updates news (page 11)

14 April 2026

RWE installs two substations for Nordseecluster A

Two offshore substations (~40×22 m; 1,800 & 2,500 t) were installed ~50 km north of Juist after transport from Saint‑Nazaire by heavy‑lift Gulliver. Nordseecluster A: 660 MW (2027); B: +900 MW (2029)
14 April 2026

thyssenkrupp-backed European Resilience Alliance launches to scale clean hydrogen deployment

CEO-led alliance white paper diagnoses bottlenecks—fragmented rules, high power costs, weak demand certainty—and urges bankable demand, simpler support, de-risk finance and cross-border infrastructure
14 April 2026

Novo Nordisk partners with OpenAI to speed drug discovery and delivery

Integrate advanced AI across drug discovery, manufacturing, supply chain and commercial ops to speed development, upskill staff; pilots now, full integration by end-2026; strict governance.
13 April 2026

Clariant launches Hostapon CT solid, a salt-free mild taurate surfactant

New surfactant offers 90% actives, long-lasting silky foam, strong oil stability, low-salt formulation flexibility, mildness for dry/sensitive skin, 80% RCI and ready biodegradability.
13 April 2026

Daiichi Sankyo and Merck: FDA Priority Review for Ifinatamab Deruxtecan in ES‑SCLC

BLA for ifinatamab deruxtecan accepted and granted FDA Priority Review for adult ES‑SCLC post‑platinum therapy; PDUFA Oct 10, 2026. Based on IDeate‑Lung01 Phase 2 (B7‑H3 DXd ADC).
13 April 2026

Johnson & Johnson reports positive 12‑month VARIPULSE results at EHRA 2026

12‑month post‑market study: 84.2% freedom from atrial arrhythmia (90.5% paroxysmal; 75.3% persistent); 0.8% primary adverse events; CE‑mark allows ablation beyond pulmonary veins

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

← Previous Next →